Latest On Evonik Industries AG (EVKIF):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-06-01 06:01 EST | Dividend | A dividend of $1.17 has been announced on Mar 7, 2023. It will be paid Jun 5, 2023 with an ex-dividend date of Jun 1, 2023. | Neutral |  |
| 2023-05-10 23:26 EST | News | Evonik: A Slow Q1, But There Are Underlying Signs Of Improvement | N/A | |
| 2023-03-03 15:21 EST | News | Evonik: We'll Just Keep On Waiting | N/A | |
| 2022-11-21 19:03 EST | News | Evonik: Long-Term Thesis Confirmed | N/A | |
| 2022-11-13 08:29 EST | News | Evonik Industries AG (EVKIF) Q3 2022 Earnings Call Transcript | N/A | |
| 2022-11-13 08:29 EST | News | Evonik Industries AG 2022 Q3 - Results - Earnings Call Presentation | N/A | |
| 2022-11-08 22:59 EST | News | Evonik Industries Non-GAAP EPS of €0.54, revenue of €4.88B | N/A | |
| 2022-09-23 19:21 EST | News | Evonik: Earnings Defensiveness | N/A | |
| 2022-08-11 03:11 EST | News | Evonik Industries AG 2022 Q2 - Results - Earnings Call Presentation | N/A | |
| 2022-08-11 03:11 EST | News | Evonik Industries AG (EVKIF) CEO Christian Kullmann on Q2 2022 Results - Earnings Call Transcript | N/A | |
| 2022-08-10 09:13 EST | News | Evonik Industries GAAP EPS of $1.14, revenue of $5.86B beats by $1.3B | N/A | |
| 2022-06-02 18:30 EST | News | Evonik gets US government funding for $220M lipid production site for mRNA therapies | N/A | |
| 2022-05-26 05:59 EST | Dividend | A dividend of $1.17 has been announced on Mar 4, 2022. It will be paid May 31, 2022 with an ex-dividend date of May 26, 2022. | Neutral | |
| 2022-03-03 21:47 EST | News | Evonik Industries Non-GAAP EPS of €2.12, revenue of €14.95B | N/A | |
| 2022-03-03 21:47 EST | News | Evonik Industries AG 2021 Q4 - Results - Earnings Call Presentation | N/A | |
| 2022-03-03 21:47 EST | News | Evonik Industries' (EVKIF) CEO Christian Kullmann on Q4 2021 Results - Earnings Call Transcript | N/A | |
| 2021-11-08 23:43 EST | News | Evonik Industries reports Q3 results | N/A | |
| 2021-11-07 05:59 EST | News | Evonik Industries AG's (EVKIF) CEO Christian Kullmann on Q3 2021 Results - Earnings Call Transcript | N/A | |
| 2021-11-06 12:49 EST | News | Evonik Industries AG 2021 Q3 - Results - Earnings Call Presentation | N/A | |
| 2021-09-03 06:48 EST | News | Evonik: Under-The-Radar German High Yielder | N/A | |
| 2021-06-03 06:13 EST | Dividend | A dividend of $1.15 has been announced on Mar 4, 2021. It will be paid Jun 8, 2021 with an ex-dividend date of Jun 3, 2021. | Neutral | |
| 2021-04-08 01:40 EST | News | Exxon Mobil is said to consider sale of Advanced Elastomer Systems unit | N/A | |
| 2021-03-07 09:15 EST | Financials | Company financials have been released. | Neutral | |
| 2021-03-06 06:17 EST | News | Evonik Industries AG 2020 Q4 - Results - Earnings Call Presentation | N/A | |
| 2021-03-05 10:25 EST | News | Evonik Industries AG (EVKIF) CEO Christian Kullmann on Q4 2020 Results - Earnings Call Transcript | N/A | |
| 2021-03-04 13:35 EST | News | Evonik Industries reports FY results | N/A | |
| 2020-11-26 22:50 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-08 01:52 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-07 21:51 EST | News | Evonik Portfolio Optimization Positions Them Further Into Specialty Chemicals | N/A | |
| 2020-11-07 18:15 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-26 15:08 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-26 10:00 EST | News | Evonik Industries (EVKIF) Investor Presentation - Slideshow | N/A | |
| 2020-09-17 07:14 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-01 06:00 EST | Dividend | A dividend of $0.58 has been announced on Jul 16, 2020. It will be paid Sep 3, 2020 with an ex-dividend date of Sep 1, 2020. | Neutral | |
| 2020-08-28 13:00 EST | News | Evonik scoops up Porocel for $210M, to accelerate growth of catalysts business | N/A | |
| 2020-08-14 11:09 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-08 07:36 EST | News | Evonik Industries AG (EVKIF) CEO Christian Kullmann on Q2 2020 Results - Earnings Call Transcript | N/A | |
| 2020-08-07 06:25 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-06 14:45 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-06 10:30 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-06 05:02 EST | News | Evonik Industries AG 2020 Q2 - Results - Earnings Call Presentation | N/A | |
| 2020-08-05 03:09 EST | News | Evonik Industries reports Q2 results | N/A | |
| 2020-07-30 18:54 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 06:53 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-29 23:05 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-27 14:46 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-23 19:32 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-09 10:58 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-01 18:42 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-01 02:28 EST | Financials | Company financials have been released. | Neutral | |
About Evonik Industries AG (EVKIF):
Evonik Industries AG engages in the specialty chemicals business. It operates through Specialty Additives, Nutrition & Care, Smart Materials, Performance Materials, and Services segments. The Specialty Additives segment provides polyurethane additives, organically modified silicones, isophorones, epoxy curing agents, oil additives, fumed silicas, matting agents, TAA and TAA derivatives, and acetylenic diol-based surfactants for consumer goods and specialized industrial applications. The Nutrition & Care segment offers amphoteric surfactants, ceramides, phytosphingosines, oleochemicals, quaternary derivatives, amino acids and amino acid derivatives, synthesis products, pharmaceutical polymers, and DL-methionine for use in consumer goods, animal nutrition, and healthcare products. The Smart Materials segment provides hydrogen peroxide, activated nickel catalysts, precious metal powder catalysts, peracetic acid, oil and fat hydrogenation catalysts, amorphous polyalphaolefins, polybutadienes, polyester resins, thermoplastic and reactive methacrylate resins, PEEK, polyamide 12, organosilanes, chlorosilanes, fumed silicas, fumed metal oxides, and precipitated silicas for the automotive, paints, coatings, adhesives, construction, and various other sectors. The Performance Materials segment produces polymer materials and intermediates, including butene-1, DINP, isononanol, cyanuric chloride, alkoxides, and superabsorbent for rubber, plastics, and automotive industries. The Services segment provides site management, utilities and waste management, technical, process technology, engineering, and logistics services. It operates in the Asia-Pacific, Europe, the Middle East, Africa, Central and South America, and North America. The company is headquartered in Essen, Germany. Evonik Industries AG is a subsidiary of RAG-Stiftung.
General
- Name Evonik Industries AG
- Symbol EVKIF
- Type Common Stock
- Exchange PINK
- Currency USD
- Country USA
- SectorBasic Materials
- IndustrySpecialty Chemicals
- Full Time Employees 31,731
- Fiscal Year EndDecember
- Web URLhttp://corporate.evonik.com/en/
Valuation
- Trailing PE 13.57
- Forward PE 16.16
- Price/Sales (Trailing 12 Mt.) 1.13
- Price/Book (Most Recent Quarter) 1.66
- Enterprise Value Revenue 1.15
- Enterprise Value EBITDA 7.09
Financials
- Most Recent Quarter 2020-12-31
- Profit Margin 4%
- Return on Assets 3%
- Return on Equity 6%
- Earnings Per Share $2.60
- Revenue Per Share $0
- Gross Profit 3.37 billion
- Quarterly Earnings Growth -2.2%
ESG Rating
Highlights
- Market Capitalization 16.28 billion
- PEG Ratio 1.85
- Book Value Per Share $19.61
Share Statistics
- Shares Outstanding 466 million
- Shares Float 191.06 million
- % Held by Insiders 5890%
- % Held by Institutions 19.61%
Technicals
- Beta 1.31
- 52 Week High $36.1
- 52 Week Low $18.27
- 50 Day Moving Average 34.13
- 200 Day Moving Average 30.3
Dividends
- Forward Annual Dividend Rate $1.39
- Forward Annual Dividend Yield 3.96%
- Payout Ratio 108%
- Dividend Date N/A
- ExDividend Date 2021-06-03
- Dividend Per Share $1.34
- Dividend Yield 0%
Evonik Industries AG (EVKIF) Dividend Calendar:
Evonik Industries AG pays out 108% of its earnings out as a dividend.
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Evonik Industries AG (EVKIF) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2020-12-31 | $N/A | $0.18 | ||
| 2020-09-30 | 2020-12-31 | $N/A | $0.21 | $0.38 | -45.55% |
| 2020-06-30 | 2020-09-30 | $N/A | $0.38 | $0.27 | 38.96% |
| 2020-03-31 | 2020-06-30 | $N/A | $0.30 | $0.41 | -27.88% |
| 2019-12-31 | 2020-03-31 | $3.28 billion | $0.32 | $0.41 | -21.27% |
| 2019-09-30 | 2019-12-31 | $3.23 billion | $0.49 | $0.46 | 6.52% |
| 2019-06-30 | 2019-09-30 | $3.31 billion | $0.36 | $0.53 | -32.55% |
| 2019-03-31 | 2019-06-30 | $3.29 billion | $0.46 | $0.49 | -6.24% |
| 2018-12-31 | 2019-03-31 | $3.68 billion | $0.50 | $0.36 | 39.61% |
| 2018-09-30 | 2018-12-31 | $3.79 billion | -$0.11 | $0.68 | -115.94% |
| 2018-06-30 | 2018-09-30 | $3.87 billion | $0.68 | $0.69 | -1.97% |
| 2018-03-31 | 2018-06-30 | $3.68 billion | $0.59 | $0.61 | -2.69% |
| 2017-12-31 | 2018-03-31 | $3.57 billion | $0.59 | $0.37 | 58.19% |
| 2017-09-30 | 2017-12-31 | $3.56 billion | $0.29 | $0.54 | -47.02% |
| 2017-06-30 | 2017-09-30 | $3.61 billion | $0.57 | $0.58 | -1.03% |
| 2017-03-31 | 2017-06-30 | $0.56 | $0.52 | 8.4% | |
| 2016-12-31 | 2017-03-31 | $0.34 | $0.34 | 0.41% | |
| 2016-09-30 | 2016-12-31 | $0.27 | $0.48 | -43.5% | |
| 2016-06-30 | 2016-09-30 | $0.54 | $0.51 | 5.25% | |
| 2016-03-31 | 2016-06-30 | $0.39 | $0.50 | -21.78% | |
| 2015-12-31 | 2016-03-31 | $0.59 | $0.41 | 44.44% | |
| 2015-09-30 | 2015-12-31 | $0.31 | $0.61 | -49.97% | |
| 2015-06-30 | 2015-09-30 | $0.45 | $0.65 | -31.32% | |
| 2015-03-31 | 2015-06-30 | $1.01 | $0.54 | 87.87% | |
| 2014-12-31 | 2015-03-31 | $0.62 | $0.40 | 54.05% | |
| 2014-09-30 | 2014-12-31 | $0.39 | $0.41 | -4.1% | |
| 2014-06-30 | 2014-09-30 | $0.45 | |||
| 2014-03-31 | 2014-06-30 | $0.33 | |||
| 2013-12-31 | 2014-03-31 | $0.45 | |||
| 2013-09-30 | 2013-12-31 | $0.13 | |||
| 2013-06-30 | 2013-09-30 | $0.35 | $0.00 | ||
| 2013-03-31 | 2013-06-30 | $0.44 | $0.00 | ||
| 2012-12-31 | 2013-03-31 | $0.79 | $0.00 | ||
| 2012-09-30 | 2012-12-31 | $0.72 | $0.00 | ||
| 2012-06-30 | 2012-09-30 | $0.94 | $0.00 | ||
| 2012-03-31 | 2012-06-30 | $0.70 | $0.00 | ||
| 2011-12-31 | 2012-03-31 | $0.72 | $0.00 | ||
| 2011-09-30 | 2011-12-31 | $0.41 | $0.00 | ||
| 2011-06-30 | 2011-09-30 | $0.98 | $0.00 | ||
| 2011-03-31 | 2011-06-30 | $0.54 | $0.00 | ||
| 2010-12-31 | 2011-03-31 | $1.30 | $0.00 | ||
| 2010-09-30 | 2010-12-31 | $0.34 | $0.00 |
Evonik Industries AG (EVKIF) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date | Dec 31 2020 | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 |
|---|---|---|---|---|---|
| Research Development | N/A | N/A | N/A | N/A | 113 million |
| Income Before Tax | N/A | N/A | N/A | N/A | 232 million |
| Selling General Administrative | N/A | N/A | N/A | N/A | 525 million |
| Gross Profit | N/A | N/A | N/A | N/A | 857 million |
| Ebit | N/A | N/A | N/A | N/A | 354 million |
| Operating Income | N/A | N/A | N/A | N/A | 354 million |
| Income Tax Expense | 21 million | 69 million | 34 million | 57 million | 25 million |
| Total Revenue | N/A | N/A | N/A | N/A | 3.28 billion |
| Cost of Revenue | N/A | N/A | N/A | N/A | 2.43 billion |
| Total Other Income Expense Net | N/A | N/A | N/A | N/A | -122 million |
| Net Income From Continuing Operations | N/A | N/A | N/A | N/A | 207 million |
| Net Income Applicable to Common Shares | 72 million | 149 million | 114 million | 130 million | 161 million |
Cash Flow:
| Date | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 |
|---|---|---|---|---|---|
| Investments | N/A | N/A | N/A | -380 million | -1.21 billion |
| Change to Liabilities | -70 million | -98 million | -18 million | 28 million | -123 million |
| Total Cash Flow from Investing Activities | 38 million | 41 million | -289 million | -632 million | 741 million |
| Net Borrowings | -125 million | -147 million | -123 million | -53 million | -196 million |
| Total Cash Flow from Financial Activities | N/A | N/A | N/A | -97 million | -223 million |
| Change to Operating Activities | 81 million | -231 million | 95 million | -88 million | 18 million |
| Change in Cash | N/A | N/A | N/A | -367 million | 992 million |
| Total Cash from Operating Activities | 535 million | 276 million | 297 million | 358 million | 471 million |
| Depreciation | N/A | N/A | N/A | 238 million | 252 million |
| Other Cash Flow from Investing Activities | 13 million | 8 million | 6 million | 31 million | -11 million |
| Change to Inventory | N/A | N/A | N/A | 186 million | 23 million |
| Change to Account Receivables | N/A | N/A | N/A | 64 million | 103 million |
| Other Cash Flow from Financing Activities | 11 million | -46 million | -29 million | -40 million | -30 million |
| Change to Net Income | 89 million | 160 million | 34 million | -232 million | -1.28 billion |
| Capital Expenditures | N/A | N/A | N/A | 313 million | 210 million |
Balance Sheet:
| Date | Dec 31 2020 | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 |
|---|---|---|---|---|---|
| Total Liabailities | N/A | N/A | N/A | N/A | 12.96 billion |
| Total Stockholder Equity | N/A | N/A | N/A | N/A | 8.97 billion |
| Other Current Liabilities | 811 million | 2.15 billion | N/A | N/A | 973 million |
| Total Assets | N/A | N/A | N/A | N/A | 22.02 billion |
| Common Stock | 466 million | 466 million | 466 million | 466 million | 466 million |
| Other Current Assets | 380 million | 283 million | N/A | N/A | 402 million |
| Retained Earnings | 6.88 billion | 7.03 billion | 7.34 billion | 7.64 billion | 7.34 billion |
| Other Liabilities | 6.31 billion | 9.64 billion | 5.71 billion | 5.52 billion | 5.71 billion |
| Other Assets | 3.23 billion | 1.92 billion | 1.85 billion | 1.79 billion | 2.6 billion |
| Cash | N/A | N/A | N/A | N/A | 1.17 billion |
| Total Current Liabilities | 2.93 billion | 3.25 billion | N/A | N/A | 3.55 billion |
| Other Stockholder Equity | 670 million | 799 million | 993 million | 1.05 billion | 1.16 billion |
| Property, Plant & Equipment | 6.16 billion | 7.14 billion | 7.24 billion | 7.28 billion | 6.33 billion |
| Total Current Assets | 4.96 billion | 5.66 billion | N/A | N/A | 6.61 billion |
| Long Term Investments | N/A | N/A | N/A | N/A | 626 million |
| Net Tangible Assets | 2.14 billion | 2.39 billion | 2.73 billion | 2.9 billion | 3.11 billion |
| Short Term Investments | N/A | N/A | N/A | N/A | 1.22 billion |
| Long Term Debt | N/A | N/A | N/A | N/A | 3.16 billion |
| Inventory | 1.81 billion | 1.97 billion | N/A | N/A | 1.88 billion |
| Accounts Payable | 1.27 billion | 1.11 billion | N/A | N/A | 1.32 billion |
Evonik Industries AG (EVKIF) Chart:
Evonik Industries AG (EVKIF) News:
Below you will find a list of latest news for Evonik Industries AG (EVKIF) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Evonik Industries AG (EVKIF) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
Evonik Industries AG (EVKIF) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|